Scholars Central

Conference abstractPublished 2014

Adiponectin may improve diabetic nephropathy

Authors: Hiroaki Satoh

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetic nephropathy is a major microvascular complication. However, there are no entirely effective remedies to prevent the progression of diabetic nephropathy. Adiponectin has been shown to exert largely beneficial effects on insulin resistance and atherosclerosis. Recently, it has been reported that plasma adiponectin levels are inversely correlated with the degree of albuminuria in obese patients, and that adiponectin-deficient mice exhibit albuminuria and podocyte dysfunction. This suggests that adiponectin may play a protective role in improving kidney disease. However, the effects of adiponectin in diabetic nephropathy are still unknown. To investigate the effects of adiponectin in diabetic nephropathy, we used an adenovirus to chronically overexpress adiponectin (Ad-Adipo) in streptozotocin (STZ) induced diabetic nephropathy rats. At 10 weeks of STZ injection, diabetic rats were injected with Ad-Adipo or Ad-lacZ. At 2 weeks of adenovirus injection, fasting glucose levels was similar in two group, whereas the degree of proteinuria significantly reduced by 24.3% (P<0.05) in Ad-Adipo rats compared with Ad-lacZ rats, suggesting the improvement of early stage diabetic nephropathy in hyperadiponectinemia animals. Nephrin, a protein found in podocytes, is crucial for maintaining the integrity of the intact glomerular filtration barrier. Nephrin mRNA expression level was significantly increased by 68.0% (P<0.01) in the renal cortex of Ad-Adipo rats. Furthermore, endothelial dysfunction correlates with progression of diabetic nephropathy. ET-1 and PAI-1 mRNA expression levels were significantly decreased by 33.4% (p<0.01) and 34.7% (P<0.01) in the renal cortex of Ad-Adipo rats, respectively, whereas eNOS mRNA expression level was significantly increased by 117.2% in the renal cortex of Ad-Adipo rats (P<0.01). In conclusion, we have shown that chronic hyperadiponectinemia inhibits the progression of glomerulo-endothelial dysfunction in early stage diabetic nephropathy. The mechanism whereby adiponectin decreases proteinuria involves an increase of nephrin expression, and an improvement of the endothelial dysfunction due to decreases of ET-1 and PAI-1, and an increase of eNOS expression in the renal cortex. Thus, chronic overexpression of adiponectin has beneficial effects on early stage diabetic nephropathy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Diabetes & Metabolism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Metabolism
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Hiroaki Satoh”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels